Bio-Rad Introduces New Multiplex Assays for Research into Human Diabetes, Angiogenesis and Acute Phase Response

Bio-Rad Laboratories, Inc. a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the release of new Bio-Plex^® Pro™ Human Disease assays that allow multiplex measurement of human diabetes (14 targets), angiogenesis (9 targets)and acute phase response (9 targets) biomarkers to help researchers understand the underlying causes of disease progression and help develop earlier diagnosis, better prevention measures and more effective therapies.

Bio-Plex Pro assays are carried out on magnetic beads and reproducibly detect human disease biomarkers over the concentration ranges reported for normal and disease conditions. Multiple biomarkers in samples such as serum, plasma and culture supernatants are measured simultaneously on the Bio-Plex Suspension Array system where sophisticated analysis software produces a complete view of their expression profiles.

Key features and benefits include: multiplexing for maximum information from each sample, new targets and combinations, results in under 4 hours for greater productivity, low volume requirements for analysis of hard to replace samples and the option of magnetic washing protocols for less hands-on time.